Prior Art Litigation Search in Dublin.

A prior art search Dublin litigation counsel can build a defence on has to match where the fights come from — and in the Irish capital that means pharma, software, medtech and data centres. Dublin is the European base for much of the world’s technology and life-sciences industry, from Google and Amazon Web Services to nine of the ten largest pharmaceutical companies. When those portfolios are asserted, the validity fight lands in the High Court in Dublin, and because Ireland has signed but not ratified the Unified Patent Court Agreement, there is no Irish UPC division to hear it. PerspireIP builds invalidity-grade searches for the parties challenging those patents before the Irish courts, the Controller and the EPO.

Where a prior art search Dublin case is actually heard

Irish patent litigation is heard by the High Court, which sits in Dublin and holds jurisdiction over infringement and validity actions under the Patents Act 1992 (as amended). In practice the substantial patent cases are admitted to the Commercial Court, a division of the High Court that runs a fast-track, case-managed list before a small pool of specialist judges. Cases in the Commercial Court are typically resolved in months rather than the years an ordinary High Court action can take — a decisive advantage when an injunction is hanging over a Dublin manufacturing or data-centre operation.

The Commercial Court generally admits commercial disputes valued at €1 million or more, but intellectual-property proceedings can be entered regardless of the amount at stake, so patent actions reach the fast track on their subject-matter alone. A dedicated Intellectual Property and Technology List has since been developed within the Commercial Court, concentrating patent and technology disputes before judges with the relevant expertise. Appeals run to the Court of Appeal and, exceptionally, to the Supreme Court.

• High Court (Commercial Court), Dublin — fast-track, case-managed forum for Irish patent infringement and revocation
• Controller of the IPOI — an administrative route for patent revocation, an alternative to the High Court
• EPO Opposition Division — a central attack on a European patent within nine months of grant
• No Irish UPC division — Ireland has not ratified the UPC Agreement, so unitary-patent revocation cannot be filed from Dublin

Ireland signed the UPC but has not ratified it

Ireland signed the Agreement on a Unified Patent Court more than a decade ago, but it has never ratified it — and that gap changes the whole invalidity strategy for a Dublin dispute. Ratifying the UPC would transfer patent jurisdiction from the Irish courts to an international court, which the Irish Constitution does not permit without an amendment. Ratification therefore requires a constitutional referendum, and until the electorate approves one, Ireland stays outside the system.

That referendum keeps slipping. A vote pencilled in for June 2024 was postponed, hopes of pairing it with the October 2025 presidential election came to nothing, and the government’s later competitiveness plans dropped any firm commitment. The UPC’s own Court of Appeal has confirmed that Ireland sits outside the court’s jurisdiction. The practical consequence is simple: there is no Irish local division, no unitary patent takes effect in Ireland, and a patent asserted here is challenged through the national routes — High Court or Controller revocation — and, for European patents, through central EPO opposition. Prior art scoped for those forums, not for a UPC that Dublin cannot use, is what wins the case.

Pharma, software and medtech: where Dublin’s patent fights come from

Dublin’s litigation profile is defined by the industries clustered around it. Ireland is the world’s third-largest exporter of pharmaceuticals, host to nine of the ten biggest pharma companies and eighteen of the top twenty-five medical-device makers, so life-sciences patents — small molecules, formulations, biologics, dosage regimes and devices — drive a large share of the docket. These are the assertions where a generic or biosimilar entrant, or a device competitor, needs to knock out the asserted claim before launch.

Layered on top is one of Europe’s densest technology clusters. Dublin is the EMEA headquarters for Google, Meta, Microsoft, Amazon Web Services, Apple, Oracle, Salesforce and LinkedIn, and the country’s data-centre capacity underpins much of that cloud infrastructure. The result is a second stream of disputes over software, networking, cloud, security and interface patents. A prior art search Dublin counsel commissions therefore has to reach two very different bodies of art: the journal, compound and clinical-trial record on the life-sciences side, and the standards, source-code and grey-literature record on the software side.

That mix also shapes who sits on the accused side of the table. In Dublin the defendant is often a generic pharmaceutical company timing a launch, a medical-device maker facing a competitor’s assertion, or a global technology firm whose EMEA operation has been sued over a widely implemented feature. For each of them the commercial stakes ride on whether the asserted claim can be shown to be old — and the most durable answer is nearly always a piece of art the patentee’s own examiner never saw.

Revoke at the Controller or the High Court: Ireland’s two national routes

An accused party in Ireland has a genuine choice of forum for revocation, and the choice matters. A patent’s validity can be challenged either before the Controller of the Intellectual Property Office of Ireland or in the High Court. The Controller route is an administrative alternative that can be quicker and less costly; the High Court route sits alongside an infringement action and lets validity and infringement be decided together, usually on the Commercial Court fast track.

The grounds are set by section 58 of the Patents Act 1992. A patent can be revoked because its subject-matter is not patentable — that is, it lacks novelty, inventive step or industrial applicability — because the specification does not disclose the invention clearly and completely enough to be carried out, because the disclosure extends beyond the application as filed (added matter), because protection was extended by an impermissible amendment, or because the proprietor is not entitled to the patent. Novelty and inventive step are the grounds that turn on prior art, and they are exactly where an invalidity search does its work.

• Lack of novelty — a single earlier disclosure that anticipates the claim
• Lack of inventive step — obviousness over the prior art, often a combination of references
• Insufficiency — the specification does not enable the skilled person to work the invention
• Added matter — the granted claims reach beyond the application as filed
• Entitlement — the proprietor is not the person entitled to the patent

EPO opposition: the nine-month central attack

Most valuable patents asserted in Dublin arrive as European patents validated in Ireland through the EPO, and that opens a route the national courts cannot match. Within nine months of grant, anyone can file an opposition at the European Patent Office. A successful opposition revokes the patent centrally — in every state where it was validated, Ireland included — in a single proceeding, on the same novelty, inventive-step, added-matter and sufficiency grounds an Irish court would apply.

The trade-off is timing. The nine-month window closes hard, and once it has passed an accused party is left with national revocation before the High Court or the Controller. Where the window is still open, EPO opposition and Irish revocation are not rivals but partners: one rigorous prior art search, charted claim by claim, can feed an opposition and a national action at the same time, so the same references do double duty. Because Ireland cannot use the UPC, the EPO is the one truly central forum available for a Dublin dispute, which makes hitting the nine-month deadline with strong art all the more valuable.

That is why we treat the grant date of any European patent asserted in Ireland as a hard diary entry from the moment we are instructed, and why we scope opposition-grade art to the same standard a national revocation action would demand. Getting the search done inside the window preserves every route at once.

Short-term patents: unexamined rights tested only in court

Ireland also grants a short-term patent, a national right lasting up to ten years that is not substantively examined before grant. No search report and no proof of novelty are required to obtain one; the IPOI checks only formalities and a lighter threshold — the invention need merely be “not clearly lacking an inventive step”. That means the state of the art is never tested until someone challenges the patent, so validity is decided for the first time in revocation proceedings, on prior art the office never reviewed.

For an accused party this is an opportunity. A short-term patent asserted in Dublin has no examiner’s search behind it, so a well-built invalidity search frequently surfaces anticipating art the proprietor never had to overcome. Short-term patents can be revoked on the same grounds as full-term patents, and infringement actions on them may start in the Circuit Court and be transferred up to the High Court. Whichever the right, the defence stands or falls on the same thing: earlier, dated, on-point prior art.

How PerspireIP builds a Dublin invalidity search

Every engagement follows the same disciplined path. We map the asserted claims element by element, fix the priority date that actually governs each one, and search against that date rather than the filing date on the cover. For life-sciences assertions we run patent searching alongside deep non-patent retrieval — journal literature, clinical-trial registries, regulatory filings and conference abstracts — and for software and networking claims we reach the standards record, source repositories, product documentation and archived web pages, dating each reference to the day.

• Claim charting mapped to novelty and inventive step under the Patents Act 1992 and the EPC
• Deep non-patent retrieval across scientific, clinical, standards and grey-literature sources
• Public-availability dating for every reference, evidenced for journals and online disclosures alike
• Prior art scoped to your forum — Commercial Court revocation, a Controller action, or the nine-month EPO opposition window
• A written invalidity analysis and reference packages ready for the High Court, the Controller or the EPO, in English

We work alongside your Irish and European counsel as a specialist search partner, deliver to Commercial Court and EPO deadlines, and keep every engagement confidential. Whether you are a generic pharmaceutical company clearing a launch, a device or software firm facing an assertion, or litigation counsel preparing a defence for a multinational’s Dublin operation, we scale to fit — a single search, a multi-patent campaign or ongoing support across a portfolio. Send us the patent number and your key dates, and we will scope a prior art search Dublin project within one business day.

IP Landscape & Resources in Dublin

Key intellectual-property authorities and venues relevant to Dublin:

• Intellectual Property Office of Ireland (IPOI) — the national IP office that grants Irish patents; the Controller hears patent revocation applications as an alternative to the High Court
• Commercial Court (Courts Service of Ireland) — the fast-track, case-managed division of the High Court in Dublin that hears substantial patent infringement and revocation actions
• Patents Act 1992 (Irish Statute Book) — the statute setting the grounds for Irish patent revocation, including lack of novelty and inventive step under section 58
• European Patent Office (EPO) — grants European patents validated in Ireland and runs post-grant opposition, a central attack filed within nine months of grant

Request a Prior Art Search in Dublin

Explore related PerspireIP services: Prior Art Litigation Search · Patent Invalidation · Patent Infringement Analysis.

Frequently Asked Questions